IDEXX Laboratories Inc(IDXX): Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDEXX Laboratories Inc(IDXX):

IDXX 628.56

+0.2%

Oct 30 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

From: JakeStraw	10/30/2015 1:34:12 PM
	of 2

IDEXX Laboratories Announces Third Quarter Results finance.yahoo.com -- Achieves 12% normalized organic revenue growth and Adjusted EPS of $0.54, reflecting continued strong gains in instrument consumable and reference lab sales, and improved growth in rapid assay revenues -- Delivers 54% increase in premium instrument placements driven by record 1,325 Catalyst® and 865 premium hematology instrument placements -- Refines 2015 outlook and provides preliminary financial guidance for 2016 for 8%-9% organic revenue growth and 13%-16% constant currency Adjusted EPS growth

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext